Fennec Pharmaceuticals Q1 EPS $(0.23) Misses $(0.21) Estimate, Sales $1.68M Miss $1.85M Estimate

Benzinga · 05/11/2023 10:05
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 64.29 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $1.68 million which missed the analyst consensus estimate of $1.85 million by 9.35 percent.